# Hetlioz LQ

NDC: 43068-304
Generic name: tasimelteon
Labeler / Manufacturer: Vanda Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SUSPENSION
Routes: ORAL
Marketing started: 20201210

FDA application: NDA214517

## Active ingredients

- TASIMELTEON: 4 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43068-304"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43068-304
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ca4a9b63-708e-49e9-8f9b-010625443b90